2009年美国血液学年会快讯  

Briefing from American Society of Hematology Annual Meeting

作　　者：马军[1] 邱林[1] 张颢[1] 

机构地区：[1]哈尔滨血液病肿瘤研究所

出　　处：《中国处方药》2009年第12期42-44,共3页Journal of China Prescription Drug

摘　　要：本次会议汇聚了中国的300多名医生,中国也成为亚洲参会人数最多的国家,我们有理由相信在未来国际交流的舞台上,会有更多来自中国的声音。The 51st American Society of Hematology Annual Meeting and Exposition was held in Ernest N. Morial Convention Center,New Orleans,LA during December 5th and 8th,2009. The highlights included:chronic myeloid leukemia:after a decade of imatinib;in the treatment of acute myeloid leukemia(AML) ,several new compounds with activity against FLT3 mutations are piquing the interest of researchers;the representatives from Shanghai Ruijin Hospital presented Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL.

关 键 词：血液学年会 美国 国际交流 中国 

分 类 号：R-2[医药卫生]